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Intermittent Pneumatic Compression (IPC) in the Treatment
of Peripheral Arterial Occlusive Disease (PAOD) e A Useful Tool
or Just Another Device?The effect of intermittent pneumatic compression
(IPC) on arterial inflow to the lower limb has been
explored by several investigators.1e5 Independently,
they concluded that there is physiological justification
for investigating IPC as a therapy for patients with
peripheral arterial occlusive disease (PAOD).1e5
There are several mechanisms by which a positive
effect on the lower limb tissue perfusion is conferred
by the use of IPC. These include emptying of the
plantar venous plexus, reduction of the venous leg
pressure, increase of the arterio-venous pressure
gradients in dependent patients, increase of arterial
flow, release of vasodilators (nitric oxide e NO, pros-
tacyclins), reduction of local vascular resistance, and
transient suspension of the arterio-venous reflex.6,7
In an extensive review of the literature 26 reports
were identified between the years 1966 to 2001.8 In
this review they included the subject profile: age, clin-
ical presentation, duration of symptoms, and resting
ankle-brachial index (ABPI). They looked at treatment
options like the type of pump used, duration of treat-
ment, pattern of pump pressure cycles and whether or
not the patients received aspirin. The measurement of
vascular changes studied included: initial claudica-
tion distance (ICD), absolute claudication distance
(ACD), post exercise ABPI, popliteal artery volume
flow, peak venous velocity, skin blood flow and tem-
perature, Laser Doppler flow, transcutaneous oxygen
pressure and venous pressure via cannulation. Due
to the individuality of each study direct comparison
was difficult. However, the following trends were
observed with the use of IPC:
i. Lower extremity arterial flow in the popliteal,
anterior and posterior tibial and peroneal arteries,
increased from between 13% to 240%.
ii. The flow of arterial blood measured by Laser
Doppler increased from 57% to 246%.
iii. The velocity of arterial flow increased from
between 155% to 320%.884/000309+ 02 $32.00/0  2006 Published by Elsevier Ltd.iv. Peak systolic and end diastolic velocities and
pulse volume all increased but the results were re-
ported using different parameters and therefore
were not comparable.
v. Rest pain was relieved from 16% to 100%.
vi. ICD and ACD increased from 146% to 197% and
from 106% to 212%, respectively. Some studies
reported on the healing of ulcers. Resting ABPI
increased between 17% to 26%.
The conclusion from the review was that the use of
IPC for the treatment of PAOD appears to be promis-
ing and may be used in patients with severe PAOD
who are not candidates for revascularization using
PTA or surgery.
Consequently, several other investigators who
considered clinical end points such as improvement
in ICD and ACD, quality of life and haemodynamic
measurements reported independently that IPC had
beneficial effect that was maintained up to a year.9e14
Gardner et al., studied the effect of supervised exercised
and found that compared to baseline, at 6 months, the
ICD and ACD increased by 189% and 80% respectively
(p< .001).15 When they continued with the supervised
exercise the initial benefit was sustained for an addi-
tional year. Kakkos et al., compared the effect of unsu-
pervised exercise (n¼ 9), supervised exercise (n¼ 12)
and IPC (foot and calf) (n¼ 13) on patients with stable
claudication for longer than 6 months, due to superfi-
cial femoral artery occlusion.10 Compared with unsu-
pervised exercise, both IPC and supervised exercise,
increased ICD andACDup to 2.83 times. IPC increased
arterial inflow (<0.05) at 6weeks andABPI. In both IPC
and supervised exercise the quality of life score
improved and at one year the clinical effectiveness
was largely preserved.10
Recently, the Mayo clinic reported their experi-
ence on 48 patients who underwent minor foot am-
putation (toe, metatarsal, forefoot) during the years
1998e2004.16 These patients were divided in two
310 Editorialgroups of 24 patients each. In the treatment group the
patients received IPC prior to and after the minor foot
amputation while in the control group no IPC treat-
ment was offered. Twenty patients in the control group
(83%) had to undergo a below knee amputation while
in the treatment group this was needed in only 10 pa-
tients (42%). They concluded that the use of IPC as an
adjunct to a standard wound care regiment in patients
with chronic clinical limb ischemia who undergo local
foot amputation it is associated with better wound
healing and higher chances of foot salvage.
The optimal device appears to be the foot and calf
IPC that gives 3 impulses per minute with a delay of
1 sec for calf compression and has an inflation pres-
sure of 120 mmHg that lasts 4 seconds. The recom-
mendation is to use the IPC daily, in a sitting
position for a total duration of about 3 hours daily.17
Additional clinical effects of IPC are: the mainte-
nance of flow in a failing lower limb graft, reduction
of limb oedema and compartmental pressure after in-
jury, elimination of tissue damage, alleviation of rest
pain and prevention of venous thromboembolism.
All the above may expand the indications for the
use of IPC when balloon angioplasty is not possible,
when the patient is high risk of peri-operative mortal-
ity, when distal arterial beds are unsuitable for graft
implantation and in graft failure when the patient is
not suitable for further surgery.
The advantage from the use of IPC is that it can be
administered at home because the device is portable,
the treatment is flexible and can be initiated at the
most convenient time during the day for each patient,
and therefore, it has high compliance while it is free of
complications.
In conclusion, IPC not only could be an alternative
in the treatment of PAOD, but it may be used as an
adjunct to other treatment. A large multicentre, rando-
mized trial with long follow-up is needed. The
cost-effectiveness of such treatment should also be
assessed.
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